REFERENCES
- Ovid MEDLINE, Accessed February 14, 2006
- Pizzichini E, Pizzichini M M, Leigh R, Djukanovic R, Sterk P J. Safety of sputum induction. Eur Respir J Suppl 2002; 37: 9s–18s, [INFOTRIEVE], [CSA]
- Wong H H, Fahy J V. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med 1997; 156: 299–303, [INFOTRIEVE], [CSA]
- Castagnaro A, Chetta A, Foresi A, D'Ippolito R, Malorgio R, Olivieri D. Effect of sputum induction on spirometric measurements and arterial oxygen saturation in asthmatic patients, smokers, and healthy subjects. Chest 1999; 116: 941–945, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Umeno E, McDonald D M, Nadel J A. Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation. J Clin Invest 1990; 85: 1905–1908, [INFOTRIEVE], [CSA]
- Fahy J V, Boushey H A, Lazarus S C, Mauger E A, Cherniack R M, Chinchilli V M, Craig T J, Drazen J M, Ford J G, Fish J E, Israel E, Kraft M, Lemanske R F, Martin R J, McLean D, Peters S P, Sorkness C, Szefler S J. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163: 1470–1475, [INFOTRIEVE], [CSA]
- Gershman N H, Wong H H, Liu J T, Mahlmeister M J, Fahy J V. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J 1996; 9: 2448–2453, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wilson A M, Leigh R, Hargreave F E, Pizzichini M MM, Pizzichini E. Safety of sputum induction in moderate to severe smoking related chronic obstructive pulmonary disease. J COPD 2006, this issue[CSA]
- Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276, [PUBMED], [INFOTRIEVE], [CSA]
- Brightling C E, Monterio W, Green R H, Parker D, Morgan M D, Wardlaw A J, Pavord D. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001; 95: 999–1002, [INFOTRIEVE], [CSA], [CROSSREF]
- Rytila P H, Lindqvist A E, Laitinen L A. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 1116–1119, [INFOTRIEVE], [CSA], [CROSSREF]
- Sutherland E R, Pak J, Langmack E L, Silkoff P E, Martin R J. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002; 96: 482–486, [INFOTRIEVE], [CSA], [CROSSREF]
- Sutherland E R, Cherniack R M. Management of chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2689–2697, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Celli B R, Cote C G, Marin J M, Casanova C, Montes de Oca M, Mendez R A, Pinto Plata V, Cabral H J. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005–1012, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sont J K, Willems L N, Bel E H, van Krieken J H, Vandenbroucke J P, Sterk P J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159: 1043–1051, [INFOTRIEVE], [CSA]
- Green R H, Brightling C E, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw A J, Pavord I D. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715–1721, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Smith A D, Cowan J O, Brassett K P, Herbison G P, Taylor D R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163–2173, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brightling C E, Monteiro W, Ward R, Parker D, Morgan M D, Wardlaw A J, Pavord I D. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356: 1480–1485, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]